Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AstraZeneca’s Farxiga Authorized Generic Aims To Broaden Access As Medicare Price Cut Looms
Apr 29 2024
•
By
Cathy Kelly
US Farxiga Sales were Up 61% In the First Quarter and 'Benefitted' from the Authorized Generic. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pricing Debate
More from Market Access